Oncolytics Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. 

CEO
Jared Kelly
CEOJared Kelly
Employees
28
Employees28
Headquarters
Calgary, Alberta
HeadquartersCalgary, Alberta
Founded
1998
Founded1998
Employees
28
Employees28

ONCY Key Statistics

Market cap
106.70M
Market cap106.70M
Price-Earnings ratio
-3.50
Price-Earnings ratio-3.50
Dividend yield
Dividend yield
Average volume
1.14M
Average volume1.14M
High today
$0.9999
High today$0.9999
Low today
$0.9501
Low today$0.9501
Open price
$0.97
Open price$0.97
Volume
592.82K
Volume592.82K
52 Week high
$1.51
52 Week high$1.51
52 Week low
$0.3258
52 Week low$0.3258

Stock Snapshot

As of today, Oncolytics Biotech(ONCY) shares are valued at $0.99. The company's market cap stands at 106.7M, with a P/E ratio of -3.50.

During the trading session on 2026-03-14, Oncolytics Biotech(ONCY) shares reached a daily high of $1.00 and a low of $0.95. At a current price of $0.99, the stock is +4.2% higher than the low and still -1.0% under the high.

Trading activity shows a volume of 592.82K, compared to an average daily volume of 1.14M.

The stock's 52-week range extends from a low of $0.33 to a high of $1.51.

The stock's 52-week range extends from a low of $0.33 to a high of $1.51.

ONCY News

TipRanks 12h
Oncolytics Biotech Director Makes Bold Insider Move With Fresh Share Purchase

New insider activity at Oncolytics Biotech ( (ONCY) ) has taken place on March 13, 2026. Director James T. Parsons has increased his stake in Oncolytics Biotec...

Simply Wall St 5d
Is Oncolytics Biotech Pricing Reflect The Gap To Its DCF Estimated Value

If you are wondering whether Oncolytics Biotech's current share price reflects its true worth, you are not alone, many investors are asking the same question be...

Is Oncolytics Biotech Pricing Reflect The Gap To Its DCF Estimated Value

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.